| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.96B | 11.24B | 10.35B | 10.35B | 10.33B |
| Gross Profit | 6.39B | 6.46B | 7.42B | 7.26B | 7.38B |
| EBITDA | 6.04B | 5.00B | 6.83B | 6.69B | 6.85B |
| Net Income | 1.81B | 2.15B | 3.97B | 3.84B | 3.87B |
Balance Sheet | |||||
| Total Assets | 222.91B | 221.65B | 217.30B | 212.69B | 224.24B |
| Cash, Cash Equivalents and Short-Term Investments | 6.33B | 10.30B | 5.35B | 5.23B | 8.52B |
| Total Debt | 54.12B | 57.64B | 50.98B | 45.82B | 46.03B |
| Total Liabilities | 78.45B | 80.60B | 75.18B | 69.54B | 71.85B |
| Stockholders Equity | 134.73B | 131.59B | 132.41B | 133.38B | 141.72B |
Cash Flow | |||||
| Free Cash Flow | 3.80B | 4.79B | 632.00M | 1.44B | -123.00M |
| Operating Cash Flow | 4.05B | 4.96B | 3.71B | 4.14B | 2.73B |
| Investing Cash Flow | -2.48B | -3.17B | -2.94B | -2.56B | -1.42B |
| Financing Cash Flow | -5.87B | 3.21B | -607.00M | -4.57B | 1.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$67.65B | -17.53 | -2.32% | 5.04% | -3.87% | -124.27% | |
69 Neutral | HK$7.34B | 10.35 | 3.35% | 5.29% | -2.09% | -28.30% | |
69 Neutral | HK$13.23B | 10.01 | 23.68% | 3.82% | ― | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | HK$44.80B | 23.45 | 1.35% | 5.92% | -9.76% | -28.29% | |
61 Neutral | HK$18.92B | 23.11 | 1.20% | 5.77% | 2.60% | 50.07% | |
46 Neutral | HK$10.42B | -1.13 | -9.42% | ― | -25.49% | -19.64% |